Business Description
Cyfuse Biomedical KK
ISIN : JP3311800001
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.24 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.29 | |||||
Debt-to-EBITDA | -1.58 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 3.06 | |||||
Beneish M-Score | -0.17 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -25.9 | |||||
3-Year EBITDA Growth Rate | -19.5 | |||||
3-Year EPS without NRI Growth Rate | -17.8 | |||||
3-Year FCF Growth Rate | -21.8 | |||||
3-Year Book Growth Rate | 23.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 57.4 | |||||
9-Day RSI | 50 | |||||
14-Day RSI | 47.79 | |||||
6-1 Month Momentum % | 6.12 | |||||
12-1 Month Momentum % | -45.55 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.98 | |||||
Quick Ratio | 5.91 | |||||
Cash Ratio | 5.81 | |||||
Days Inventory | 675.34 | |||||
Days Sales Outstanding | 40.19 | |||||
Days Payable | 57.47 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.4 | |||||
Shareholder Yield % | -0.45 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 61.76 | |||||
Operating Margin % | -1141.24 | |||||
Net Margin % | -964.15 | |||||
FCF Margin % | -951.97 | |||||
ROE % | -17.1 | |||||
ROA % | -13.28 | |||||
ROIC % | -85.22 | |||||
ROC (Joel Greenblatt) % | -243.89 | |||||
ROCE % | -15.17 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 90.58 | |||||
PB Ratio | 1.75 | |||||
Price-to-Tangible-Book | 1.74 | |||||
EV-to-EBIT | -4.54 | |||||
EV-to-EBITDA | -4.54 | |||||
EV-to-Revenue | 42.7 | |||||
EV-to-FCF | -4.2 | |||||
Price-to-Net-Current-Asset-Value | 1.87 | |||||
Price-to-Net-Cash | 1.94 | |||||
Earnings Yield (Greenblatt) % | -22.09 | |||||
FCF Yield % | -10.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cyfuse Biomedical KK Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 61.112 | ||
EPS (TTM) (円) | -75.423 | ||
Beta | 0 | ||
Volatility % | 48.04 | ||
14-Day RSI | 47.79 | ||
14-Day ATR (円) | 21.404691 | ||
20-Day SMA (円) | 704.35 | ||
12-1 Month Momentum % | -45.55 | ||
52-Week Range (円) | 647 - 1490 | ||
Shares Outstanding (Mil) | 7.9 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cyfuse Biomedical KK Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cyfuse Biomedical KK Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
Cyfuse Biomedical KK Frequently Asked Questions
What is Cyfuse Biomedical KK(TSE:4892)'s stock price today?
When is next earnings date of Cyfuse Biomedical KK(TSE:4892)?
Does Cyfuse Biomedical KK(TSE:4892) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |